Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided dural puncture epidural vs traditional epidural for labor analgesia
ChiCTR2300067438Phase 4Not yet recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine and sufentanil in labor pain (2 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: Probability of VAS score ≤1 during uterine contraction 10 minutes after initial epidural catheter infusion. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
ropivacainesufentanil
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2300067438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067438.